Moderna Reveals First Data on Its Personalized Cancer Vaccines

(Bloomberg) -- Moderna Inc., whose initial public offering in December was one of the most hyped in biotech, gave investors their first look at its personalized cancer vaccine platform on Wednesday.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.